Stocks ended Wednesday on the upside with the news that a candidate Coronavirus vaccine from Moderna (MRNA) – Get report produced the desired immune response and that group Goldman Sachs (GS) – Get report posted stronger earnings than expected. Optimism was somewhat affected by reports that China promised to retaliate …
Read More »
CNBC’s Jim Cramer said Wednesday that he wants to see insider trading in Moderna before deciding how confident they will be about the vaccine data the pharmaceutical company released Tuesday night. “There is a document I want to see. I want to see if anyone sold any shares in Moderna …
Read More »
Moderna’s shares rose as much as 18% on Wednesday after the company announced that an early test of the coronavirus vaccine produced antibodies in all participants. A dose range induced immune responses in all 45 patients in the phase 1 trial and was “generally safe and well tolerated,” Moderna said …
Read More »
Goldman Sachs reported second-quarter earnings on Wednesday morning that exceeded earnings and earnings analysts’ estimates. Quarterly revenue posted its second highest reading as commercial companies increased due to increased market volatility. Reserves for credit losses reached $ 1.6 billion as the company prepared for the consequences of the credit market. …
Read More »
Text size It is good to be the Dow. The stock market continues to rise on Wednesday, but some indices are rising more than others. S&P 500 futures are up 1.4%, while Dow Jones Industrial Average futures are up 566 points, or 2.1%, and Nasdaq Composite is up just 0.5%. …
Read More »